BPSD	Behavioral and psychological symptoms of dementia
AD	Alzheimer’s disease
MCI	mild cognitive impairment
Aβ	amyloid-beta
ADNC	Alzheimer’s disease neuropathologic change
MBI	Mild Behavioral Impairment
HR	Hazard Ratios
MTHFR	methylenetetrahydrofolate reductase
DAM	disease-associated microglia
CSF	cerebrospinal fluid
sTREM2	soluble TREM2
LDAM	lipid-droplet-accumulating microglia
NPS	neuropsychiatric symptoms
WMH	white matter hyperintensities
OR	odds ratio
CNS	Central Nervous System
AβOs	amyloid-β oligomers
TLR4	Toll-like receptor 4
5-HT	serotonin
IL-1ra	IL-1 receptor antagonist
GDNF	glial cell line-derived neurotrophic factor
LCN2	lipocalin-2
TBARS	Thiobarbituric Acid Reactive Substances
ACC	Anterior Cingulate Cortex
ChEIs	acetylcholinesterase inhibitors
α7nAChRs	α7 nicotinic acetylcholine receptors
SERT	serotonin transporter
IDO	indoleamine-2,3-dioxygenase
DRD2	dopamine D2 receptor
CRYAB	αB-crystallin
mGluR5	metabotropic glutamate receptor 5
CIH	chronic intermittent hypoxia
LRP	Lewy-related pathology
HMGB1	high-mobility group box 1
UCP4	uncoupling protein 4
eNMDARs	extrasynaptic NMDA receptors
COPD	Chronic Obstructive Pulmonary Disease
OPCs	oligodendrocyte progenitor cells
βHB	β-hydroxybutyrate
NPI	Neuropsychiatric Inventory
DAMPs	damage-associated molecular patterns
CAT	catalase
SSRIs	selective serotonin reuptake inhibitors
iPSCs	induced pluripotent stem cells
GRP	Glial-restricted precursor
CBD	Cannabidiol
MADRS	Montgomery–Åsberg Depression Rating Scale
HAM-A	Hamilton Anxiety Rating Scale